Skip to main content
. Author manuscript; available in PMC: 2009 Dec 1.
Published in final edited form as: J Allergy Clin Immunol. 2008 Oct 25;122(6):1138–1144.e4. doi: 10.1016/j.jaci.2008.09.028

Figure 2.

Figure 2

The Conditional power in MARS, calculated as the probability of rejecting the null hypothesis of no active treatment effect if the trial had reached the target enrollment (210 randomized children), given that the active treatment and placebo groups displayed approximately a 0.5 failure rates at the interim stage (55 randomized children).